Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects. Journal of Advances and Scholarly Researches in Allied Education, [S. l.], v. 16, n. 6, p. 3589–3595, 2019. Disponível em: https://ignited.in/index.php/jasrae/article/view/11970. Acesso em: 4 apr. 2026.